MULLER, ILARIA
 Distribuzione geografica
Continente #
AS - Asia 2.992
NA - Nord America 2.774
EU - Europa 2.336
SA - Sud America 449
Continente sconosciuto - Info sul continente non disponibili 235
AF - Africa 132
OC - Oceania 36
Totale 8.954
Nazione #
US - Stati Uniti d'America 2.473
CN - Cina 1.081
IT - Italia 788
SG - Singapore 664
BR - Brasile 259
HK - Hong Kong 249
BD - Bangladesh 241
DE - Germania 234
GB - Regno Unito 216
RU - Federazione Russa 192
IN - India 179
FR - Francia 167
SE - Svezia 140
MX - Messico 136
CA - Canada 124
VN - Vietnam 117
NL - Olanda 112
FI - Finlandia 91
JP - Giappone 84
ES - Italia 80
TR - Turchia 78
ID - Indonesia 70
IE - Irlanda 55
AR - Argentina 50
CO - Colombia 46
KR - Corea 43
PL - Polonia 38
AU - Australia 30
CI - Costa d'Avorio 30
PE - Perù 26
PH - Filippine 26
AT - Austria 25
GR - Grecia 23
CL - Cile 22
LY - Libia 22
BE - Belgio 20
CH - Svizzera 20
IR - Iran 20
VE - Venezuela 18
BH - Bahrain 16
DZ - Algeria 16
UA - Ucraina 16
EG - Egitto 15
HU - Ungheria 15
TW - Taiwan 15
ZA - Sudafrica 15
DK - Danimarca 14
SA - Arabia Saudita 14
PT - Portogallo 12
EC - Ecuador 11
MY - Malesia 11
PK - Pakistan 11
AE - Emirati Arabi Uniti 10
PY - Paraguay 10
MA - Marocco 9
NO - Norvegia 9
RO - Romania 9
SI - Slovenia 9
LU - Lussemburgo 8
BG - Bulgaria 7
ET - Etiopia 7
JO - Giordania 7
KE - Kenya 7
CZ - Repubblica Ceca 6
DO - Repubblica Dominicana 6
HR - Croazia 6
IL - Israele 6
NI - Nicaragua 6
NP - Nepal 6
NZ - Nuova Zelanda 6
IQ - Iraq 5
OM - Oman 5
QA - Qatar 5
SV - El Salvador 5
TH - Thailandia 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
CR - Costa Rica 4
LT - Lituania 4
RS - Serbia 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
GE - Georgia 3
HN - Honduras 3
JM - Giamaica 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
PA - Panama 3
TN - Tunisia 3
UZ - Uzbekistan 3
BB - Barbados 2
BO - Bolivia 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
MK - Macedonia 2
MN - Mongolia 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
Totale 8.702
Città #
Singapore 357
Ashburn 308
Hong Kong 197
Milan 192
Chandler 174
San Jose 154
Beijing 124
Council Bluffs 121
Santa Clara 112
Dallas 106
Los Angeles 106
Fairfield 102
Frankfurt am Main 101
Helsinki 79
New York 76
Southend 68
Hefei 66
Princeton 58
Bengaluru 51
Rome 51
Woodbridge 50
Dublin 49
Jakarta 47
Seattle 47
Shanghai 47
Houston 46
Toronto 45
Kent 44
Ho Chi Minh City 43
Guangzhou 42
Buffalo 38
Lauterbourg 37
Tokyo 34
Istanbul 33
Abidjan 30
Hangzhou 29
São Paulo 29
Cambridge 28
London 27
Munich 27
Redwood City 27
Madrid 26
Moscow 26
Hanoi 25
Lima 25
Wilmington 25
Des Moines 24
Chicago 23
Tripoli 19
Shenyang 18
San Diego 17
Santiago 17
Amsterdam 16
Ankara 16
Athens 16
Chennai 16
Florence 16
Naples 16
Nuremberg 16
Seoul 16
Warsaw 16
Wuhan 16
Belo Horizonte 15
Berlin 15
Vienna 15
Atlanta 14
Buenos Aires 14
Guadalajara 14
Mazatlán 14
Central 13
Manama 13
Bogotá 12
Chengdu 12
Mexico City 12
Montreal 12
Newark 12
San Francisco 12
Shenzhen 12
Boardman 11
Delhi 11
Hyderabad 11
Nanjing 11
New Delhi 11
Sydney 11
Washington 11
Cangzhou 10
Jinan 10
Lappeenranta 10
Palermo 10
Phoenix 10
Tianjin 10
Trieste 10
Turin 10
Asunción 9
Genoa 9
Marseille 9
Nagoya 9
Ottawa 9
Taiyuan 9
Boston 8
Totale 4.237
Nome #
Efficacy profile and safety implications of very low dose Rituximab in patients with graves' orbitopathy 852
Indications for treatment of subclinical hypothyroidism and isolated hypothyroxinaemia in pregnancy 757
Controlled Antenatal Thyroid Screening II: Effect of Treating Maternal Suboptimal Thyroid Function on Child Cognition 460
The antigenic link between thyroid autoimmunity and breast cancer 389
SARS-CoV-2-related atypical thyroiditis 283
Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) during Alemtuzumab Therapy : Evidence that TRAb May Precede Thyroid Dysfunction by Many Years 282
SARS-COV-2 specific t-cells in patients with thyroid disorders related to COVID-19 are enriched in the thyroid and acquire a tissue-resident memory phenotype 274
Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism : A Phase i Study 215
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy 208
Hypercalcaemia with undetectable parathormone levels 196
CATS II long-term anthropometric and metabolic effects of maternal sub-optimal thyroid function in offspring and mothers 193
Long-term outcome of thyroid abnormalities in patients with severe Covid-19 188
Case Report: A Novel ARMC5 Germline Mutation in a Patient with Primary Bilateral Macronodular Adrenal Hyperplasia and Hypogammaglobulinemia 186
Thyroid function in pregnancy 185
High prevalence of breast cancer in patients with benign thyroid diseases 182
Asymmetry indicates more severe and active disease in Graves’ orbitopathy : results from a prospective cross-sectional multicentre study 180
Increased risk of Thyroid Eye Disease following Covid-19 Vaccination 177
Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab 176
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy 172
2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy 169
Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer? 155
Gut microbiome associated with Graves' disease and Graves' orbitopathy: the INDIGO* multi-centre European study 154
The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen 152
Expression of endogenous putative tsh binding protein in orbit 147
Clinical and Visual Outcomes of Dysthyroid Optic Neuropathy after Surgical Orbital Decompression 144
Microbiota Alterations in Patients with Autoimmune Thyroid Diseases: A Systematic Review 144
Alemtuzumab-induced thyroid dysfunction exhibits distinctive clinical and immunological features 144
Thyroid findings in pediatric and adult patients with PTEN hamartoma tumor syndrome: A retrospective analysis, and literature review 141
TPOAb and Thyroid Function Are Not Associated with Breast Cancer Outcome : Evidence from a Large-Scale Study Using Data from the Taxotere as Adjuvant Chemotherapy Trial (TACT, CRUK01/001) 139
Controlled Antenatal Thyroid Screening II : Effect of Treating Maternal Suboptimal Thyroid Function on Child Behavior 138
Is the risk of primary hyperparathyroidismincreased in patients with untreated breast cancer? 136
Liothyronine cost and prescriptions in England 131
La gestione degli eventi avversi endocrini 127
Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies 119
Subacute thyroiditis in the SARS-CoV-2 era: a multicentre prospective study 119
Combination Thyroid Hormone Replacement; Knowns and Unknowns 110
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy 109
Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer 109
Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination 106
Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current Update 100
Role of hyaluronan in human adipogenesis : Evidence from in-vitro and in-vivo studies 94
IGF-II mRNA expression in breast cancer: predictive value and relationship to other prognostic factors 93
Clinical management of alemtuzumab-induced autoimmune thyroid diseases: a narrative review 83
The second wave of the Controlled antenatal thyroid screening (CATS II) study : the cognitive assessment protocol 80
Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves' Orbitopathy : A Randomized Controlled Double-Masked Crossover Trial (BIMA Trial) 77
Studio prospettico randomizzato EUGOGO sull'efficacia di due diversi dosaggi di metilprednisolone per via endovenosa nel trattamento della neuropatia ottica distiroidea acuta: dati preliminari 68
Successful outcome of Rituximab treatment based on lymphocyte immunophenotyping in active Thyroid Eye Disease: a case report 52
Intelligenza Artificiale nella gestione del paziente con Oftalmopatia Tiroidea: Innovazioni e Applicazioni 51
Autoimmune Thyroid Disease 5
null 3
Totale 8.954
Categoria #
all - tutte 26.721
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.721


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022578 0 0 20 15 42 82 63 54 89 45 69 99
2022/2023917 95 94 91 47 84 100 56 67 69 41 107 66
2023/20241.166 76 69 90 102 211 88 82 63 44 130 87 124
2024/20251.965 69 173 65 261 165 126 176 185 105 178 168 294
2025/20263.167 286 260 289 282 253 174 341 168 329 171 332 282
2026/2027466 229 227 10 0 0 0 0 0 0 0 0 0
Totale 8.954